Package 63402-202-28

{"route": ["ORAL"], "spl_id": "3af99c5d-50e2-4336-8a5e-e93b6cf3618a", "openfda": {"unii": ["BEA68ZVB2K"], "rxcui": ["1482507", "1482513", "1482515", "1482517", "1482521", "1482523", "1482525", "1482527", "1491642", "1491643"], "spl_set_id": ["3d0c9554-eaeb-4694-8089-00133fcadce3"], "manufacturer_name": ["Sumitomo Pharma America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 BLISTER PACK in 1 CARTON (63402-202-28)  / 7 TABLET in 1 BLISTER PACK (63402-202-07)", "package_ndc": "63402-202-28", "marketing_start_date": "20170913"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (63402-202-30)", "package_ndc": "63402-202-30", "marketing_start_date": "20140407"}], "brand_name": "Aptiom", "product_id": "63402-202_3af99c5d-50e2-4336-8a5e-e93b6cf3618a", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "63402-202", "generic_name": "ESLICARBAZEPINE ACETATE", "labeler_name": "Sumitomo Pharma America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aptiom", "active_ingredients": [{"name": "ESLICARBAZEPINE ACETATE", "strength": "200 mg/1"}], "application_number": "NDA022416", "marketing_category": "NDA", "marketing_start_date": "20140407", "listing_expiration_date": "20261231"}